摩通:港交所(0388.HK)首季純利遜預期 予目標價460港元
摩根大通發表研究報吿指,港交所(0388.HK)首季純利按年跌31%至26.68億港元,遜預期,主要是由於較高的息率造成相當大的按市值計價損失,其餘的收入和成本線表現出色。該行維持其“增持”評級,目標價460港元。
摩通指,港交所期內的交易、清算、託管和上市費用均高於預期;成本控制良好,不過管理層指,在薪金和一系列計劃舉措的推動下,成本可能維持在高水平。
摩通又提到,港交所第二季度投資收益的虧損也可能持續,但可能低於第一季度,因為債務證券的損失是由於投資組合持續時期和利率環境變化,認為投資者將能預期其收入遜預期。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.